Johnson & Johnson is a large-cap company that ranks as one of the world's biggest medical device makers. It markets medical devices that include catheters, implants, robotic surgical systems, surgical instruments, and wound closure products. J&J is also a top maker of prescription drugs.
Acquisitions have played a big role in helping Johnson & Johnson grow its medical device business. In recent years, the healthcare giant has acquired several medtech companies, including Abiomed and Verb Surgical.
Johnson & Johnson spun off its consumer health unit into a separate publicly traded entity, Kenvue (KVUE -0.40%), in May 2023. The move could enable the company to deliver even stronger long-term growth.
The stock remains a favorite for income investors, too. J&J has increased its dividend for an impressive 64 consecutive years, making it one of the top Dividend Kings in the market.